Uni-Bio Science Group Limited
UNBSF
$0.0036
$0.00360.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.97M | 17.91M | 17.50M | 17.49M | 15.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.97M | 17.91M | 17.50M | 17.49M | 15.02M |
| Cost of Revenue | 3.14M | 3.13M | 2.75M | 2.75M | 2.61M |
| Gross Profit | 14.82M | 14.78M | 14.75M | 14.74M | 12.41M |
| SG&A Expenses | 11.04M | 11.01M | 9.00M | 9.00M | 8.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -171.80K | -171.30K | -183.00K | -183.00K | -374.50K |
| Total Operating Expenses | 16.03M | 15.98M | 12.91M | 12.90M | 12.65M |
| Operating Income | 1.94M | 1.93M | 4.59M | 4.59M | 2.37M |
| Income Before Tax | 1.26M | 1.26M | 4.58M | 4.57M | 2.08M |
| Income Tax Expenses | 272.40K | 271.50K | 266.10K | 266.00K | 65.90K |
| Earnings from Continuing Operations | 989.90K | 986.80K | 4.31M | 4.31M | 2.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 989.90K | 986.80K | 4.31M | 4.31M | 2.01M |
| EBIT | 1.94M | 1.93M | 4.59M | 4.59M | 2.37M |
| EBITDA | 2.19M | 2.18M | 5.13M | 5.13M | 2.78M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 6.12B | 6.12B | 6.16B | 6.16B | 6.36B |
| Average Diluted Shares Outstanding | 6.12B | 6.12B | 6.16B | 6.16B | 6.36B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |